EurekaMag
+ Translate
+ Most Popular
Advantages and disadvantages of bordeaux mixture and of lime-sulphur used on apples in the growing season
Observations on the Umaria marine bed
10 years of hearing conservation in the Royal Air Force
Chocolate crumb - dairy ingredient for milk chocolate
Effect of daily gelatin ingestion on human scalp hair
Comparison of rice bran and maize bran as feeds for growing and fattening pigs
The composition of pampas-grass (Cortaderia argentea.)
The Accraian Series:
The mechanism of the Liebermann-Burchard reaction of sterols and triterpenes and their esters
Cerebrovascular Doppler ultrasound studies (cv-Doppler)
Toria: PT-303 - first national variety
Hair growth promoting activity of tridax procumbens
Productivity of Pekin x Khaki Campbell ducks
A stable cytosolic expression of VH antibody fragment directed against PVY NIa protein in transgenic potato plant confers partial protection against the virus
Solar treatment of wheat loose smut
Swimmers itch in the Lake of Garda
Bactofugation and the Bactotherm process
The effects of prefrontal lobotomy on aggressive behavior in dogs
Visual rating scales for screening whorl-stage corn for resistance to fall armyworm
Breakdown of seamounts at the trench axis, viewed from gravity anomaly
Kooken; pennsylvania's toughest cave
Recovery of new dinosaur and other fossils from the Early Cretaceous Arundel Clay facies (Potomac Group) of central Maryland, U.S.A
Zubor horny (Bison bonasus) v prirodnych podmienkach Slovensku
The extended Widal test in the diagnosis of fevers due to Salmonella infection
Hair of the american mastodon indicates an adaptation to a semi aquatic habitat

Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii


Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii



Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 8(6): 504-505



ISSN/ISBN: 0941-4355

PMID: 11094997

DOI: 10.1007/s005200000123

A case of Saccharomyces fungemia in an 8-month-old baby affected by acute myeloid leukemia while receiving intensive chemotherapy is reported. The patient was receiving prophylaxis treatment with Saccharomyces boulardii capsules (Codex) to prevent diarrhea, which is commonly associated with this type of chemotherapy. Fever spiked just the day after ending the chemotherapy course, and a strain of Saccharomyces cerevisiae was isolated from blood culture although the patient was also receiving antifungal prophylaxis with fluconazole. The patient recovered, though still neutropenic, with amphotericin-B and removal of the central venous catheter. The common biochemical characteristics make it difficult to differentiate between the strain of Saccharomyces cerevisiae and that of Saccharomyces boulardii with routine methods. In other cases, authors demonstrated an identity between the two strains with a more detailed analysis. These reports raise concern about the potential side effects of such biotherapeutic agents.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 003553147

Download citation: RISBibTeXText

Related references

Saccharomyces cerevisiae fungemia in an immunocompromised patient not treated with Saccharomyces boulardii preparation. Journal of Infection 54(3): 310-311, 2007

Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 28(4): 930, 2000

Saccharomyces cerevisiae fungemia: an adverse effect of Saccharomyces boulardii probiotic administration. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 40(11): 1635-1637, 2005

Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. Journal of Clinical Gastroenterology 36(1): 41-43, 2003

Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii. American Journal of Medicine 105(1): 71-72, 1998

Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in an elderly patient. Revista Argentina de Microbiologia 52(1): 27-30, 2020

Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment: In a child in intensive care unit and review of the literature. Medical Mycology Case Reports 15: 33-35, 2017

Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. Journal of Clinical Microbiology 41(11): 5340-5343, 2003

Saccharomyces cerevisiae presenting as skin rash and fungemia in a neutropenic patient. Clinical Infectious Diseases 25(2): 460, 1997

Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment. Medical Mycology Case Reports 18: 15-17, 2017

Saccharomyces cerevisiae boulardii transient fungemia after intravenous self-inoculation. Medical Mycology Case Reports 2: 63-64, 2013

Saccharomyces cerevisiae fungemia: Risk factors, outcome and links with S. boulardii-containing probiotic administration. Infectious Diseases now 51(3): 293-295, 2021

Saccharomyces fungemia complicating Saccharomyces boulardii treatment in a non-immunocompromised host. Intensive Care Medicine 26(6): 825, 2000

Saccharomyces boulardii fungemia in a patient with severe burns. Annales Francaises d'Anesthesie et de Reanimation 14(4): 356-358, 1995

Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities. Deutsche Medizinische Wochenschrift 128(48): 2531-2533, 2003